Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine

GSK Investigational Site, Hamburg

GSK Investigational Site, Altenholz

GSK Investigational Site, Neumünster

GSK Investigational Site, Flensburg

GSK Investigational Site, Flensburg

GSK Investigational Site, Brunsbüttel

GSK Investigational Site, Husum

GSK Investigational Site, Bredstedt

GSK Investigational Site, Kirchlengern

GSK Investigational Site, Löhne

GSK Investigational Site, Detmold

GSK Investigational Site, Gütersloh

GSK Investigational Site, Marburg/Lahn

GSK Investigational Site, Fulda

GSK Investigational Site, Salzgitter

GSK Investigational Site, Wolfenbüttel

GSK Investigational Site, Bochum

GSK Investigational Site, Münster

GSK Investigational Site, Trier

GSK Investigational Site, Mainz

GSK Investigational Site, Mainz

GSK Investigational Site, Gau-Algesheim

GSK Investigational Site, Bad Kreuznach

GSK Investigational Site, Bad Sobernheim

GSK Investigational Site, Nidderau

GSK Investigational Site, Wiesbaden

GSK Investigational Site, Hochheim am Main

GSK Investigational Site, Rüsselsheim am Main

GSK Investigational Site, Bad Camberg

GSK Investigational Site, Schoeneberg - Kuebelberg

GSK Investigational Site, Frankenthal

GSK Investigational Site, Worms

GSK Investigational Site, Olching

GSK Investigational Site, Tutzing

GSK Investigational Site, Tegernsee

GSK Investigational Site, Bindlach

GSK Investigational Site, Marktredwitz

GSK Investigational Site, Klagenfurt

GSK Investigational Site, Neufeld/Leitha

GSK Investigational Site, Salzburg

GSK Investigational Site, Villach